Stock PBAJ PETRO USA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Petro USA, Inc.

Equities

PBAJ

US71648P1030

Pharmaceuticals

Market Closed - OTC Markets
Other stock markets
 04:07:47 2024-04-30 pm EDT 		5-day change 1st Jan Change
5 USD +212.50% Intraday chart for Petro USA, Inc. -.--% +11.11%
Feb. 21 Petro USA, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
2023 Petro USA, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023 CI

Valuation

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Capitalization 1 0.5928 1.186 0.5928 0.0618 1,000 1,598
Enterprise Value (EV) 1 0.5928 1.186 0.5928 0.0654 1,000 1,598
P/E ratio -17.8 x -86.4 x -34.2 x -2.21 x -76,923 x -67,143 x
Yield - - - - - -
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA - - - - - -
EV / FCF - - - - - -
FCF Yield - - - - - -
Price to Book -9.91 x -16.1 x -6.52 x -0.56 x -9,579 x -12,465 x
Nbr of stocks (in thousands) 29.6 29.6 29.6 30.9 200,031 200,031
Reference price 2 20.00 40.00 20.00 2.000 5.000 7.990
Announcement Date 10/9/18 7/10/20 7/14/20 10/21/21 10/14/22 10/13/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net sales - - - - - -
EBITDA - - - - - -
EBIT 1 -0.0333 -0.0137 -0.0173 -0.028 -0.0129 -0.0236
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 -0.0333 -0.0137 -0.0173 -0.028 -0.0131 -0.0239
Net income 1 -0.0333 -0.0137 -0.0173 -0.028 -0.0131 -0.0239
Net margin - - - - - -
EPS 2 -1.123 -0.4628 -0.5848 -0.9057 -0.000065 -0.000119
Free Cash Flow - - - - - -
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 10/9/18 7/10/20 7/14/20 10/21/21 10/14/22 10/13/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt - - - 0 0 0
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - - - - - -
ROE (net income / shareholders' equity) 77.1% 20.6% 21.1% 27.7% 12.2% 20.5%
ROA (Net income/ Total Assets) - - - - - -
Assets 1 - - - - - -
Book Value Per Share 2 -2.020 -2.480 -3.070 -3.600 -0 -0
Cash Flow per Share - - - - - -
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 10/9/18 7/10/20 7/14/20 10/21/21 10/14/22 10/13/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
PETRO USA, INC. Stock Petro USA, Inc.
+11.11% 1B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+30.38% 684B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.51% 568B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.36% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.30% 329B
ABBVIE INC. Stock AbbVie Inc.
+3.73% 284B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.70% 240B
NOVARTIS AG Stock Novartis AG
+8.78% 208B
ROCHE HOLDING AG Stock Roche Holding AG
-7.93% 200B
AMGEN INC. Stock Amgen Inc.
+7.68% 166B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. PBAJ Stock
  4. Financials Petro USA, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW